Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Carnosol is a naturally occurring **phenolic diterpene** found primarily in rosemary (Rosmarinus officinalis) and sage (Salvia carnosa)[1][2][4]. It is a product of the oxidative degradation of carnosic acid and is characterized by an abietane carbon skeleton with ortho-diphenolic and lactone moieties[1]. Carnosol exhibits a range of biological and pharmacological activities including potent **antioxidant, anti-inflammatory, antimicrobial, and anticarcinogenic effects**[1][4][5][7]. Mechanistically, it acts as: - An inhibitor of **cyclooxygenase-2 (COX-2) induction** by blocking protein kinase C (PKC) signaling, - A **dual antagonist** of the **androgen receptor (AR)** and **estrogen receptor alpha (ERα)**, - An inhibitor of **5-lipoxygenase (5-LO)** and leukotriene synthesis[4][5]. Carnosol also targets heat-shock protein 90 (**HSP90**), inhibiting its ATPase activity to block activation of the **NLRP3 inflammasome** and thereby modulating inflammation[3]. It activates **peroxisome proliferator-activated receptor gamma (PPARγ)** and suppresses multiple pro-inflammatory and tumorigenic signaling pathways including NF-κB and MAPKs[5]. Preclinical studies have demonstrated **chemopreventive effects** in various cancer models (e.g., prostate, breast, skin, leukemia, colon), and efficacy in animal models of **NASH** and **sepsis**[1][3][5]. Carnosol is widely used in research and as a nutraceutical ingredient, but it is **not approved as a pharmaceutical drug** in any jurisdiction as of August 2025[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on carnosol.